key: cord-0977707-ddhq0exu authors: Campi, Riccardo; Tellini, Riccardo; Grosso, Antonio Andrea; Amparore, Daniele; Mari, Andrea; Viola, Lorenzo; Cocci, Andrea; Polverino, Paolo; Checcucci, Enrico; Alessio, Paolo; Fiori, Cristian; Minervini, Andrea; Carini, Marco; Porpiglia, Francesco; Serni, Sergio title: Deferring Elective Urologic Surgery During the COVID-19 Pandemic: the Patients’ Perspective date: 2020-09-24 journal: Urology DOI: 10.1016/j.urology.2020.09.015 sha: b1e40e90faf3ddc13d9869ca63d72919b9fe8643 doc_id: 977707 cord_uid: ddhq0exu OBJECTIVES: To explore the perspective of urological patients on the possibility to defer elective surgery due to the fear of contracting COVID-19. METHODS: All patients scheduled for elective urological procedures for malignant or benign diseases at two high-volume Centres were administered a questionnaire, through structured telephone interviews, between 24(th) and 27(th) April 2020. The questionnaire included three questions: 1) In light of the COVID-19 pandemic, would you defer the planned surgical intervention? 2) If yes, when would you be willing to undergo surgery? 3) What do you consider potentially more harmful for your health: the risk of contracting COVID-19 during hospitalization or the potential consequences of delaying surgical treatment? RESULTS: Overall, 332 patients were included (51.5% and 48.5% in the oncology and benign groups, respectively). Of these, 47.9% patients would have deferred the planned intervention (33.3% vs 63.4%; p<0.001), while the proportion of patients who would have preferred to delay surgery for more than six months was comparable between the groups (87% vs 80%). These answers were influenced by patient age and ASA score (in the Oncology group) and by the underlying urological condition (in the benign group). Finally, 182 (54.8%) patients considered the risk of COVID-19 potentially more harmful than the risk of delaying surgery (37% vs 73%; p<0.001). This answer was driven by patient age and the underlying disease in both groups. CONCLUSIONS: Our findings reinforce the importance of shared decision-making before urological surgery, leveraging patients’ values and expectations to refine the paradigm of evidence-based medicine during the COVID-19 pandemic and beyond. The COVID-19 pandemic represents a global emergency with a major impact on healthcare systems worldwide. In this context, Urology has been significantly involved [1], with a dramatic reorganization of elective surgical activity [1-4] and a slowdown of Urology residents' learning curve [5] [6] [7] [8] . Several cross-sectional surveys, investigating the impact of COVID-19 on urological services worldwide, confirmed that the pandemic has imposed great challenges to urology health care providers. In fact, a significant cut-down in urology clinics, outpatient procedures, major surgeries, and urgent/emergent urological care has been reported [2, 9] . Soon after the spread of the pandemic, several National and International Urological Associations have provided timely recommendations to guide the prioritization of clinical and surgical activities during such a challenging context [10] [11] [12] [13] . Although it may lead to potential clinical and medico-legal implications [14, 15] , the possibility that patients may want their elective surgery to be postponed, due to the fear of contracting COVID-19 during the hospitalization, was not formally taken into account [10] [11] [12] [13] . Thus, the transferability of such recommendations to real-life clinical scenarios still needs to be investigated. From the patient's standpoint, the choice to undergo surgery during such a complex period may be particularly challenging, considering the competing risks of delaying the intervention (with possible consequences on oncologic/functional outcomes) and contracting a potentially lifethreatening disease. Aiming to optimize the decision-making during emergency scenarios such as the pandemic, in this study we explored the patients' perspective on the possibility to delay elective surgery and its drivers. A specific questionnaire was developed to investigate whether patients, scheduled for elective urological procedures (for malignant or benign diseases) at two Italian high-volume referral Centres, would have been willing to defer the planned intervention due to the fear of contracting COVID-19. Four urology residents administered the questionnaire to all patients through structured telephone interviews between 24 th and 27 th April 2020. To be included in the study, patients had to be considered eligible for surgery after a thorough anesthesiologic work-up. The priority of uro-oncological procedures (low vs high) was classified according to previously published criteria [11] . In detail, radical cystectomy (RC), radical nephroureterectomy (RNU), transurethral resection of bladder tumor, endoscopic management of upper urinary tract urothelial cancer (UTUC), radical prostatectomy (RP) for high-risk patients if not eligible for radiation, orchifuniculectomy for testicular cancer and any treatment for penil cancer were considered as high-priority uro-oncological procedures. On the other hand, all treatments for oncologic diseases not fulfilling these criteria were included in low-priority surgeries. Regarding benign conditions, upper tract functional diseases included uretero-pelvic junction obstruction, large renal cysts compressing the pelvicalyceal system, ureteral stenosis requiring ureteral stent placement, while female functional diseases included urinary incontinence and pelvic organ prolapse. Finally, andrological diseases included hydrocele, varicocele, erectile dysfunction. Baseline clinical and demographic characteristics, as well as histopathological data, were obtained from our prospectively collected Institutional databases. The study questionnaire included the following questions (Q): Patients' answers were recorded in a priori developed database. The primary outcome of the study was the proportion of patients willing to defer their planned surgical intervention if scheduled during the COVID-19 pandemic. An exploratory analysis was performed to evaluate the potential influence of patient-and/or disease-specific characteristics on such perspective. Descriptive statistics were reported as the median and IQR for continuous variables, and the frequency and proportion for categorical variables, as appropriate. The potential influence of baseline characteristics on patients' answers was evaluated by the Pearson Chi-square or Mann-Whitney test, as appropriate. Statistical analyses were performed using SPSS v. 24 (IBM SPSS Statistics for Mac, Armonk, NY, IBM Corp). All tests were two-sided with a significance set at p<0.05. Overall, 358 patients met the inclusion criteria. Of these, 332 (93%) were included in the analytic cohort. Reasons for exclusion were a) patient death while on the waiting list (n=4); b) impossibility to reach the patient via telephone (or email) (n=21); c) cancellation of the planned intervention (n=1). Of the included patients, 171/332 (51.5%) were scheduled for oncologic surgery, of which 19.5% classified as high-priority ( Table 1) . Figure 1 and Table 2 . Overall, 159 (47.9%) patients would have deferred the planned surgical intervention in light of the COVID-19 pandemic, with nearly 85% of them willing to postpone it for at least six months. The proportion of patients refusing surgery was significantly higher among those with benign conditions as compared to those with cancer (63.4% versus 33.3%; p<0.001) (Figure 1-Q1 ). In the oncologic disease group, the will to postpone surgery was more pronounced among older (21.2% vs 31.2% vs 55.2% for patients aged <60 ys, 61-80 ys and >80 ys, respectively, p=0.01) and frailer (44.7% vs 29.0% for ASA score >3 vs ASA score <3, p=0.03) patients. On the contrary, the priority of surgery did not influence this answer (30.6% vs 34.4% for high-vs low-priority, respectively, p=0.6). Conversely, in the benign disease group, the underlying urological condition was the only factor impacting on the attitude to defer the procedure. Namely, interventions for benign prostatic hyperplasia/female functional diseases and andrological diseases were more frequently asked to be deferred as compared to those for urolithiasis/related conditions (71.0% vs 68.8% vs 48.8%, respectively, p=0.004). The proportion of patients wishing to delay surgery for more than six months was not significantly different among the two groups (87% vs 80% in the benign and oncology groups, respectively, p=0.5) (Figure 1-Q2) . Frailer patients (ASA>3) were less likely to postpone surgery for at least six months in both cohorts (57.9% vs 92.8%, p=0.001 and 66.7% vs 91.7%, p=0.01 in the benign and oncology groups, respectively). Moreover, among patients with oncologic diseases, this answer was also influenced by the priority of surgery (88.1% vs 66.7% for low-vs high-priority, respectively, p=0.048). Overall, 182 (54.8%) patients considered the risk of contracting COVID-19 during hospitalization potentially more harmful than the risk of delaying surgery. This proportion was significantly higher among patients with benign conditions (73% vs 37%, p<0.001) (Figure 1-Q3 ). In both groups, the underlying urological condition and patient age significantly influenced this perspective ( Table 2) . Older patients were indeed more worried about the risk of COVID-19 (oncology group: 27.3% vs 32.1% vs 69.0%, p=0.01; benign group: 59.2% vs 80.0% vs 75.0%, p=0.02, for patients aged <60 ys, 61-80 ys and >80 ys, respectively). Shared decision-making is a key component of patient-centered health care. It is defined as an approach where clinicians and patients share the best available evidence when faced with the task of making decisions, aiming to achieve informed preferences [16] . In this view, to the best of our knowledge, this is the first study exploring how patients scheduled for elective urological procedures perceive their disease and the risk-benefit ratio of undergoing surgery during the COVID-19 pandemic. Our findings provide insights to contextualize and reinforce the value of shared decisionmaking in such an unprecedented period, providing an opportunity to refine both the available schemes for triage of urological procedures [12] and waiting lists, taking into account patients' wishes and fears. The compelling need to value the patients' perspective (beyond disease-specific features) during preoperative counseling is real both for oncologic and non-oncologic settings [17] . In fact, in light of the recommendations provided by most Urological Associations worldwide, the procedures that are most likely to impact on the burden of urologists' workload in the future are represented by elective surgeries for lower-risk cancers and selected benign conditions such as non-obstructing stone disease and BPH [10] . A first key finding of our study is that around one out of three patients with urological cancers would have deferred surgery, even if classified as high-priority. As such, these patients will likely represent a challenge for rescheduling waiting lists in the near future, being approximately one-third of elective cancer surgeries at referral Centres [18] . Moreover, the finding that elderly and frailer patients were more prone to postpone surgery, in light of a higher fear of contracting COVID-19, further highlights the need for careful selection of surgical candidates in this patient population [10] . It is important to note that, while the proportion of cancer patients declining intervention during the "acute" phase of the outbreak ranged between 5% and 20% at our Centres [16] , the patients included in the current study were interviewed in a later phase of the pandemic, when both the Government and the mass media were discussing the concrete possibility to reduce the lockdown. This underlines the importance of shared decision-making, as well as of structured care pathways, in patients scheduled for uro-oncological surgery during emergency periods [18, 20] . In this light, emerging proposals assessing the benefits of counseling and visits through telemedicine tools have shown encouraging insights [21] . Notably, in the non-oncologic setting, around one-third of patients with benign diseases were less likely to refuse surgery, being more concerned about the potential consequences of delaying intervention (Table 1) . These patients might be those with a higher burden of symptoms and worse quality of life, reinforcing the need for careful patient counseling. Despite its novelty, our study is not devoid of limitations. First, it was conducted at the end of the acute phase of the COVID-19 pandemic. As such, our findings might not reflect patients' perspectives during the peak of the emergency. Second, the questionnaire was administered to patients scheduled for elective surgery at two high-volume referral Centres, potentially limiting the generalizability of our results to other healthcare scenarios. Third, we could not assess whether the presence of symptoms might have influenced patients' answers. Acknowledging these limitations, our study reinforces the importance of shared decisionmaking during emergency periods such as the COVID-19 pandemic, providing an opportunity to reinterpret the available schemes for triage of urologic procedures in light of patients' values and expectations [10, 21] . In this study we explored the patients' perspective on the possibility to delay elective urologic surgery during the COVID-19 pandemic, offering insights to contextualize and reinforce the value of shared decision-making also beyond such an unprecedented scenario. In light of our findings, the paradigm of evidence-based medicine in the COVID-19 era and in the near future will require not only integration of clinical expertise with the best available evidence, but also a careful consideration of individual patients' values and expectations. Future research efforts should aim at integrating such patients' views into effective strategies to reorganize Urology practice in the upcoming phases of the pandemic. and dark grey (for disease-related variables). ASA = American Society of Anesthesiologists. Urology in the Time of Coronavirus: Reduced Access to Urgent and Emergent Urological Care during the Coronavirus Disease Forecasting the future of Urology practice: a comprehensive review of the recommendations by International and European Associations on priority procedures during the COVID-19 pandemic Considerations in the Triage of Urologic Surgeries During the COVID-19 Pandemic EAU Guidelines Office Rapid Reaction Group: An organisation-wide collaborative effort to adapt the EAU guidelines recommendations to the COVID-19 era Recommendations for Tiered Stratification of Urologic Surgery Urgency in the COVID-19 Era Assessing the Burden of Urgent Major Uro-oncologic Surgery to Guide Prioritisation Strategies During the COVID-19 Pandemic: Insights from Three Italian Highvolume Referral Centres Unknown unknowns: Surgical consent during the COVID-19 pandemic. Annals of Surgery 2020 Implementing shared decision making in the NHS The multifaceted long-term effects of the COVID-19 pandemic on urology Assessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Prioritisation Strategies During the COVID-19 Pandemic: Insights from Three Italian High-volume Referral Centres Assessing the Burden of Nondeferrable Major Urooncologic Surgery to Guide Prioritisation Strategies During the COVID-19 Pandemic: Insights from Three Italian High-volume Referral Centres Press. Available at Managing Urology Consultations During COVID-19 Pandemic: Application of a Structured Care Pathway Patients' perspective on the use of telemedicine for outpatient urological visits: learning from the COVID-19 outbreak The START (Surgical Triage And Resource Allocation Tool) of Surgical Prioritisation during the COVID-19 Pandemic